560
E. Błocka et al. / Tetrahedron: Asymmetry 25 (2014) 554–562
22.67 (2ꢁ CH3), 27.52 (CH2), 34.56 (CH2), 48.22 (C), 50.30 (C), 54.30
(CH), 77.77 (CH), 82.80 (CH), 119.09 (C), 119.12 (CH), 127.15 (C),
130.29 (CH), 134.55 (CH), 160.64 (C), 167.21 (CH). IR (HCB film)
3518.20, 3187.67 2950.47, 2879.55, 2520.16, 1604.16, 1611.20,
1564.94, 1457.34, 1170.09, 1051.74, 955.73, 941.92, 853.43,
790.41, 746.85, 656.33, 525.99 cmꢀ1, Anal. Calcd. for C18H25NO2:
C, 75.22; H, 8.77; N, 4.87. Found: C, 75.31; H, 8.80; N: 4.88.
13C NMR (400 MHz, CDCl3): d = 11.41 (CH3), 12.79 (2ꢁ CH3),
21.39 (CH3), 21.67 (CH3), 26.52 (CH2), 33.54 (CH), 44.55 (2ꢁ
CH2), 47.14 (C), 59.14 (C), 53.10 (CH), 73.54 (CH), 80.83 (CH),
98.84 (CH), 103.44 (CH), 108.44 (C), 133.63 (CH), 152.43 (C),
162.95 (CH), 168.84 (C), IR (HCB film) 3294.11, 2924.36, 2857.14,
2717.08, 2358.54, 2252.10, 1686.71, 1608.39, 1559.59, 1496.50,
1345.45, 1166.43, 1132.86, 980.34, 937.06, 851.96, 792.47,
654.51, 542.65 cmꢀ1, Anal. Calcd. for C21H32N2O2: C, 73.22; H,
9.36; N, 8.13. Found: C, 73.18; H, 9.35; N: 8.14.
5.3.6. (1R,2S,3R,4S)-3-((E)-(2-Hydroxy-3-isopropylbenzylidene)
amino)-1,7,7-trimethylbicyclo [2.2.1]heptan-2-ol 6c
Compound 6c was prepared from 2-hydroxy-3-isopropylbenz-
aldehyde (0.48 g; 2.95 mmol) according to method B. The crude
product was purified by crystallization from methanol, 0.83 g;
5.4. Typical procedure for the asymmetric trimethylsilylcyana-
tion of aldehydes
90%. Mp. 100–103 °C, ½a D20
ꢂ
¼ þ87:4 (c 0.270, MeOH). 1H NMR
At first, Ti(O-i-Pr)4 (0.05 m; 0.18 mmol) was added to a solution
of Schiff base (0.20 mmol) in dry dichloromethane (2.5 ml) and
stirred at room temperature for 1 h under a nitrogen atmosphere.
The mixture was then cooled to an adequate temperature and
TMSCN (0.29 ml; 2.3 mmol) was added followed by the aldehyde
(1.0 mmol). The mixture was stirred at the same temperature for
48 h and poured into a mixture of 1 M HCl (30 ml) and ethyl acetate
(150 ml) and stirred vigorously for 12 h at rt. The layers were sep-
arated, and the aqueous layer was extracted with ethyl acetate
(3 ꢁ 30 ml). The combined extracts were washed with saturated
NaHCO3 (4 ꢁ 50 ml) and brine (2 ꢁ 50 ml), dried over anhydrous
sodium sulfate, and then evaporated. The residue was purified by
column chromatography on silica gel (eluent: hexane/ethyl acetate
5:1 (v/v)). The pure cyanohydrin (1 equiv) was then converted di-
rectly into the corresponding acetate by reaction with acetyl chlo-
ride (0.09 ml), and pyridine (0.004 ml) in dry CH2Cl2 (4 ml) at
room temperature under a nitrogen atmosphere for 1 hour. The
reaction was quenched by water (5 ml) and extracted with CH2Cl2
(3 ꢁ 10 ml). The organic extracts were washed with brine (10 ml)
and dried over anhydrous sodium sulfate. Evaporation of the sol-
vents gave the corresponding acetate. The enantiomeric excess of
the cyanohydrin acetate was determined by an HPLC or GC method.
(400 MHz, CDCl3): d = 0.90 (s, 3H, CH3), 1.04 (s, 3H, CH3), 1.11–
1.22 (m, 2H, CH2), 1.26 (dd, J = 7.0 Hz, J = 2.8 Hz, 2H, CH2), 1.31 (s,
6H, 2ꢁ CH3), 1.37 (S, 3H, CH3), 1.56–1.86 (m, 5H, 2ꢁ CH2, OH),
3.43 (sep, J = 14.0 Hz, 1H, CH), 3.61 (d, J = 7.2 Hz, 1H, CH), 3.84 (d,
J = 4.0 Hz, 1H, CH), 6.88 (t, J = 7.6 Hz, 1H, CHAr), 7.13 (dd,
J = 7.6 Hz, J = 1.4 Hz, 1H, CHAr), 7.29 (dd, J = 7.6 Hz, J = 1.6 Hz, 1H,
CHAr), 8.41 (s, 1H, (N)CH), 13.29 (br s, 1H, OH). 13C NMR
(400 MHz, CDCl3): d = 11.34 (CH3), 21.68 (2ꢁ CH3), 22.50 (CH3),
22.56 (CH3), 26.17 (CH), 26.54 (CH2), 33.57 (CH2), 47.22 (C),
49.31 (C), 53.31 (CH), 76.88 (CH), 81.80 (CH), 118.29 (C), 118.37
(CH), 129.17 (CH), 129.21 (CH), 136.50 (C), 158.57 (C), 166.52
(CH). IR (HCB film) 3378.15, 2956.27, 2879.55, 1686.90, 1628.93,
1610.96, 1560.19, 1439.36, 1384.61, 1403.62, 1261.53, 1170.27,
1095.91, 1046.15, 980.76, 941.63, 853.02, 824.35, 793.01, 749.65,
655.37, 495.10 cmꢀ1, Anal. Calcd. for C20H29NO2: C, 76.15; H,
9.27; N, 4.44. Found: C, 76.34; H, 9.26; N: 4.34.
5.3.7. (1R,2S,3R,4S)-3-((E)-(3,5-Di-tert-butyl-2-hydroxybenzylid-
ene) amino)-1,7,7-trimethylbicyc-lo[2.2.1]heptan-2-ol 6d12
Compound 6d was prepared from 3,5-di-tert-butyl-2-hydroxy-
benzaldehyde (0.69 g; 2.95 mmol) according to method B. The
crude product was purified by crystallization from methanol,
1.04 g; 95%. Mp. 82–85 °C, ½a D20
ꢂ
¼ þ68=2 (c 0.290, MeOH). 1H
5.5. Retention times for the cyanohydrins
NMR (700 MHz, CDCl3): d = 0.91 (s, 3H, CH3), 1.06 (s, 3H, CH3),
1.13–1.21 (m, 2H, CH2), 1.31 (s, 3H, CH3), 1.34 (s, 9H, 3ꢁ CH3),
1.47 (s, 9H, 3ꢁ CH3), 1.59–1.63 (m, 1H, CH), 1.81–1.87 (m, 2H,
CH2), 1.96 (d, J = 5.6 Hz, 1H, OH), 3.62 (d, J = 7.7 Hz, 1H, CH), 3.84
(dd, J = 7.7 Hz, J = 4.9 Hz, 1H, CH), 7.14 (d, J = 2.8 Hz, 1H, CHAr),
7.43 (d, J = 2.8 Hz, 1H, CHAr), 8.45 (s, 1H, (N)CH), 13.18 (br s, 1H,
OH). 13C NMR (400 MHz, CDCl3): d = 11.36 (CH3), 21.66 (CH3),
21.71 (CH3), 26.57 (CH2), 29.41 (3ꢁ CH3), 31.49 (3ꢁ CH3), 33.58
(CH2), 34.14 (C), 35.08 (C), 47.18 (C), 49.31 (C), 53.35 (CH), 77.05
(CH), 81.71 (CH), 118.05 (C), 126.23 (CH), 127.27 (CH), 136.79
(C), 140.21 (C), 157.90 (C), 167.44 (CH), IR (HCB film) 3398.70,
2954.63, 2860.61, 1678.48, 1640.55, 1608.39, 1559.29, 1450.63,
1439.99, 1389.16, 1272.72, 1252.02, 1171.61, 1092.92, 1057.34,
976.50, 941.27, 854.75, 792.18, 656.65, 520.37 cmꢀ1, Anal. Calcd.
for C25H39NO2: C, 77.87; H, 10.19; N, 3.63. Found: C, 77.84; H,
10.16; N: 3.69.
5.5.1. 2-Hydroxy-2-phenylacetonitrile
HPLC conditions: Chiralcel OD-H (250 ꢁ 4.6 mm,
5 lm),
T = 25 °C, eluent: hexane/i-PrOH (99:1), flow rate: 0.7 ml/min,
detection: UV–vis, k = 254 nm, tR = 27.6 min (R), tR = 35.8 min (S).
½
a 2D0
ꢂ
¼ ꢀ8:6 (c 0.500, CHCl3) for the (S)-enantiomer in 81% ee,
{lit.13
½
a 2D4
ꢂ
¼ þ36:8 (c 2.0, CHCl3) for the (R)-enantiomer in 85%
ee}. 1H NMR (400 MHz, CDCl3): d = 3.31 (br s, 1H, OH), 5.53 (s,
1H, CH(CN)), 7.31–7.43 (m, 5H, 5ꢁ CHAr).
5.5.2. 2-Hydroxy-2-(2-methoxyphenyl)acetonitrile
HPLC conditions: Chiralcel OD-H (250 ꢁ 4.6 mm,
5 lm),
T = 25 °C, eluent: hexane/i-PrOH (99:1), flow rate: 0.7 ml/min,
detection: UV–vis, k = 220 nm, tR = 19.3 min (R), tR = 21.3 min (S).
1H NMR (400 MHz, CDCl3): d = 3.68 (br s, 1H, OH), 3.86 (s, 3H,
CH3), 5.51 (s, 1H, CH(CN)), 6.90–7.23 (m, 4H, 4ꢁ CHAr).
5.3.8. (1R,2S,3R,4S)-3-((E)-(3-Diethylamino-2-hydroxybenzylid-
ene)amino)-1,7,7-trimethylbicyclo [2.2.1]heptan-2-ol 6e
Compound 6e was prepared from 2-hydroxy-3-N,N-diisopro-
pylbenzaldehyde (0.57 g; 2.95 mmol) according to method B. The
crude product was purified by crystallization from methanol,
5.5.3. 2-Hydroxy-2-(3-methoxyphenyl)acetonitrile
HPLC conditions: Chiralcel OD-J (250 ꢁ 4.6 mm, 5
lm), eluent:
hexane/i-PrOH (90:10), flow rate: 1 ml/min, detection: UV–vis,
k = 220 nm, tR = 24.5 min (R), tR = 25.8 min (S), ½a D20
ꢂ
¼ ꢀ10:2 (c
0.69, CHCl3) for the (S)-enantiomer in 97% ee, {lit.13
½ ꢂ
a 2D5
¼ ꢀ37:2
0.60 g; 57%. Mp. 204–207 °C, ½a D20
ꢂ
¼ þ57:4 (c 0.270, MeOH). 1H
(c 2.36, CHCl3) for the (S)-enantiomer in 90% ee}. 1H NMR
(400 MHz, CDCl3): d = 3.68 (br s, 1H, OH), 3.83 (s, 3H, CH3), 5.52
(s, 1H, CH(CN)), 6.90–7.30 (m, 4H, 4ꢁ CHAr).
NMR (700 MHz, CDCl3): d = 0.80 (s, 3H, CH3), 1.04 (s, 3H, CH3),
1.07–1.12 (m, 2H, CH2), 1.21 (t, J = 7.0 Hz, 6H, 2ꢁ CH3), 1.53–1.57
(m, 1H, CH), 1.76–1.79 (m, 2H, CH2), 2.15 (br s, 1H, OH), 3.36–
3.44 (m, 5H, CH, 2ꢁ CH2), 3.88 (d, J = 7.0 Hz, 1H, CH), 6.03 (d,
J = 2.1 Hz, 1H, CHAr), 6.12 (dd, J = 9.1 Hz, J = 2.8 Hz, 1H, CHAr), 6.90
(d, J = 2.1 Hz, 1H, CHAr), 7.66 (s, 1H, (N)CH), 13.40 (br s, 1H, OH).
5.5.4. 2-Hydroxy-2-(4-methoxyphenyl)acetonitrile
HPLC conditions: Chiralcel OD-J (250 ꢁ 4.6 mm, 5
lm), eluent:
hexane/i-PrOH (90:10), flow rate: 1 ml/min, detection: UV–vis,